Bioventus Inc. (BVS) is a global medical device company that focuses on developing innovative solutions for musculoskeletal health. Founded in 2012, Bioventus specializes in products that enhance the healing process for orthopedic conditions, including osteoarthritis and bone healing. The company’s mission is to improve patient outcomes by providing non-surgical treatment options that promote healing and recovery.
Bioventus offers a range of products, including biologics, orthopedic braces, and devices designed to aid in bone and joint health. One of their flagship products is Exogen, a wearable ultrasound device that accelerates bone healing, particularly in cases of non-union fractures. Additionally, the company has developed Durolane, a single-injection hyaluronic acid product used to relieve pain in osteoarthritis patients. Bioventus is committed to advancing the field of orthopedics through innovative technologies and rigorous clinical research.
The main drivers of growth for Bioventus include the increasing prevalence of musculoskeletal disorders, the aging population, and the demand for non-surgical treatment options. As healthcare providers and patients seek alternatives to traditional surgical interventions, Bioventus’s focus on biologics and regenerative medicine positions it well for expansion. Furthermore, the company’s strategic partnerships and ongoing research and development efforts aim to bring new and effective solutions to market, enhancing their product portfolio and meeting the evolving needs of healthcare providers and patients. Learn more at Bioventus Inc..
Click The Image For Current Live Chart
Click To Download Report and Backtest Data 